| Literature DB >> 24549986 |
Xiu-Ping Liu1, Xiang Qian, Yue Xie, Yan Qi, Min-Feng Peng, Bi-Cui Zhan, Zheng-Qing Lou.
Abstract
Betaine was an endogenous catabolite of choline, which could be isolated from vegetables and marine products. Betaine could promote the metabolism of homocysteine in healthy subjects and was used for hyperlipidemia, coronary atherosclerosis, and fatty liver in clinic. Recent findings shown that Betaine rescued neuronal damage due to homocysteine induced Alzheimer's disease (AD) like pathological cascade, including tau hyperphosphorylation and amyloid-β (Aβ) deposition. Aβ was derived from amyloid precursor protein (APP) processing, and was a triggering factor for AD pathological onset. Here, we demonstrated that Betaine reduced Aβ levels by altering APP processing in N2a cells stably expressing Swedish mutant of APP. Betaine increased α-secretase activity, but decreased β-secretase activity. Our data indicate that Betaine might play a protective role in Aβ production.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24549986 DOI: 10.1007/s10072-014-1630-y
Source DB: PubMed Journal: Neurol Sci ISSN: 1590-1874 Impact factor: 3.307